{"FinancialColumns":null,"FinancialHits":null,"TotalStockCount":0,"Securities":null,"OtcSecurities":null,"SortedSecurityCodes":null,"SearchId":"728574e5-1dd8-4194-b576-899b58b37399","TotalCompanyCardCount":15,"Total":19,"Took":318,"DbTook":0,"Hits":[{"Id":"kcb-92330","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"wBm1TfffbhwFdEPhPz6ESg==","EncryptionKey":"d0JtMVRmZmZiaHdGZEVQaFB6NkVTZz09","Title":"铂力特：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"688333","StockTicker":"铂力特","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207669315.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"通用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=iL9L7XEGY6x3Md6oDbQQ1YGGIc6Mc0vvJxg/bh36hz9GUbYBWADOkA==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688333/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688333\t公司简称：铂力特<br />西安铂力特增材技术股份有限公司<br />&emsp;&emsp;2019 年年度报告<br />&emsp;&emsp;重要提示<br />一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整，<br />"},"Highlight":{"Content":["@41@348@程、10大战略领域和若干重大政策举措。在这十大战略领域中，高档数控机床和机器人发展战略中，增材制造是重点发展的装备和技术之一；新材料发展战略中，3D打印用材料被明确提出作为重点发展的方向；<em>生物医药及高性能医疗器械</em>发展战略中，发展医用增材制造技术（3D打印技术）被作为关键性技术被提出。粉末原材料制备技术、增材制造装备、工艺技术、应用软件等取得飞速发展。目前整个行业正处于一个关键的转折点，增材制造业务已从设备和材料过渡到完整的端到端解决方案。聚焦新型增材制造材料、大尺寸精密增材制造装备、高性能成形工艺等关键技术研发，重点关注关键材料、核心元器件的自主研发，加快补齐材料、装备等短板，实现自主可控，推进在各领域的应用。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51306120","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"JaJ3sqd8zzjIvgLu2j2Luw==","EncryptionKey":"SmFKM3NxZDh6empJdmdMdTJqMkx1dz09","Title":"兴业股份：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"603928","StockTicker":"兴业股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207599732.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"化学原料及化学制品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=G+BwAkUGr4Q5li2g4axiKi7Dof2ElHUU/FNChl0j3tRWsTcYrs4PFQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603928/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603928 \u0000 \u0000 公司简称：\u0000 兴业股份\u0000<br />苏州兴业材料科技股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000218\u0000<br />"},"Highlight":{"Content":["@22@267@序号 \t法律法规\\产业政策 \t发布部门 \t主要相关内容<hr style='margin:2px; border:none;' />1\t中共中央关于制定国民经济和社会发展第十三个五年规划的建议（2015年10月29日）\t中国共产党第十八届中央委员会第五次全体会议\t加快突破新一代信息通信、新能源、新材料、航空航天、生物医药、智能制造等领域核心技术。实施智能制造工程，构建新型制造体系，促进新一代信息通信技术、高档数控机床和机器人、航空航天装备、海洋工程装备及高技术船舶、先进轨道交通装备、节能与新能源汽车、电力装备、农机装备、新材料、<em>生物医药及高性能医疗器械</em>等产业发展壮大。<hr style='margin:2px; border:none;' />"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314445","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"sUxKRNRoHt6A+y1ZGlUpbw==","EncryptionKey":"c1V4S1JOUm9IdDZBK3kxWkdsVXBidz09","Title":"盈康生命：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300143","StockTicker":"盈康生命","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609193.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=DXbN2oHljZWpfJsxN4/+GHETowFA+lwJGUZOUAlbfBYQntOGytZFqw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300143/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"盈康生命科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;盈康生命科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />1\u0000<br />"},"Highlight":{"Content":["》明确把新材料、<em>生物医药及高性能医疗器械</em>作为未来十年重点发展的十大领域之一。该","》明确把新材料、<em>生物医药及高性能医疗器械</em>作为重点发展的十大领域之一，提出提"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314441","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"oFY4oSWwILxP3JfgpbZA0g==","EncryptionKey":"b0ZZNG9TV3dJTHhQM0pmZ3BiWkEwZz09","Title":"盈康生命：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300143","StockTicker":"盈康生命","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609159.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=iFha6Hf0/69oJdkJ6CUD6DpoVWYZbTjog6aVRXyUCyUs98MNVhrJww==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300143/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300143 \t证券简称：盈康生命\t公告编号：2020-042<br />&emsp;&emsp;盈康生命科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;所有董事均已出..."},"Highlight":{"Content":["@8@108@目前，我国医疗器械的总体水平与国际先进水平仍有较大差距，国内中高端医疗器械主要依靠进口。《中国制造2025》明确把新材料、<em>生物医药及高性能医疗器械</em>作为未来十年重点发展的十大领域之一。该行动纲领提出，未来十年需要提高医疗器械的创新能力和产业化水平，使我国逐步摆脱高端医疗器械依赖进口的局面，不断发展和提高国产高端医疗器械水平。“十三五”规划将高性能医疗器械确定为重点突破领域，积极扶植和发展国产医疗器械产业。规划中还指出，“引导医疗机构合理配置适宜设备，逐步提高国产医用设备配置水平”、“支持社会办医院合理配置大型医用设备”等。随着医学基础研究的深入、软件开发能力和精密电子设备制造能力的提升，国产医疗器械的性能也将得到提升，进而凭借价格和服务优势，将逐步替代进口产品。","@8@111@&emsp;&emsp;《中国制造2025》明确把新材料、<em>生物医药及高性能医疗器械</em>作为重点发展的十大领域之一，提出提高医疗器械的创新能力和产业化水平，逐步摆脱高端医疗器械依赖进口的局面。《“十三五”国家科技创新规划》特别强调“十三五”时期将重点发展数字诊疗装备、体外诊断产品、健康促进关键技术、健康服务技术、养老助残技术等关键技术。《“健康中国2030”规划纲要》提出，未来15年，将深化医疗器械流通体制改革、强化医疗器械安全监管、加强高端医疗器械创新能力建设、推进医疗器械国产化。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314529","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"YqGCLR7xwcLJVQqkkqHGFA==","EncryptionKey":"WXFHQ0xSN3h3Y0xKVlFxa2txSEdGQT09","Title":"千红制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"002550","StockTicker":"千红制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609296.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=c9e6IOxjk0ORQT8bsKs6q1Ijiu964YAyz/LSfk66bV5uG6ZkJl027g==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002550/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;常州千红生化制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />常州千红生化制药股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />证券简称：千红制药\u0000证券代码：\u0000 002550\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月 \u0000 25 \u0000 日\u0000<br />"},"Highlight":{"Content":["》，将<em>生物医药及高性能医疗器械</em>列入十大重点领域之一。公司专业从事生物医"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51279176","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ZQUZ4OqBdX4QeLCT8pmeVQ==","EncryptionKey":"WlFVWjRPcUJkWDRRZUxDVDhwbWVWUT09","Title":"五矿稀土：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"000831","StockTicker":"五矿稀土","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207583133.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"有色金属冶炼和压延加工业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=u5I+dyI6Nnq7BUHsd2Q1Fg7R7HofCCWqTrMnalRsJdME3zdtne+teQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000831/2020-04-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;五矿稀土股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />五矿稀土股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>生物医药及高性能医疗器械</em>等十大重点领域与稀土产业均有相应关联。如剔除黑色稀土产业导致的冶炼分离产能过剩等因素"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51262094","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"YzgtsA0K4SMqu0iXG6Fw0w==","EncryptionKey":"WXpndHNBMEs0U01xdTBpWEc2Rncwdz09","Title":"诚益通：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-23T00:00:00","StockCode":"300430","StockTicker":"诚益通","Url":"http://static.cninfo.com.cn/finalpage/2020-04-23/1207557090.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"仪器仪表制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=CqqtW/wJEJBZwSkgWbQ8Dd1oudR/Re58/gZ1r2RCm027Bk+idl7i2w==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300430/2020-04-23 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;北京诚益通控制工程科技股份有限公司 \u0000 2019 \u0000年年度报告\u0000<br />&emsp;&emsp;北京诚益通控制工程科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000015\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["大重点领域，其中之一就是<em>生物医药及高性能医疗器械</em>。《医药工业发展规划指南》指出，"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-89221","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"QfRDpwQlT6qpInGjn9Dalg==","EncryptionKey":"UWZSRHB3UWxUNnFwSW5Ham45RGFsZz09","Title":"佰仁医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-22T00:00:00","StockCode":"688198","StockTicker":"佰仁医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-22/1207551606.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=T7leBXT+AZ/V1pL5IdIK3T9Yl+AxlDFviePmG8gagplwgq+T0/uqew==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688198/2020-04-22 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688198\t公司简称：佰仁医疗<br />北京佰仁医疗科技股份有限公司<br />2019 年年度报告<br />&emsp;&emsp;重要提示<br />一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整，<br />"},"Highlight":{"Content":["@13@137@&emsp;&emsp;2015年5月，国务院印发《中国制造2025》，将<em>生物医药及高性能医疗器械</em>作为战略产业发展方向。2016年11月，国务院印发《“十三五”国家战略性新兴产业发展规划》（国发[2016]67号），提出要加快组织器官修复和替代材料及植（介）入医疗器械产品创新和产业化。2016年12月，国家发改委印发《“十三五”生物产业发展规划》（发改高技[2016]2665号），提出要推动植（介）入产品创新发展，推动生物技术与材料技术的融合。2017年2月，国家发改委、工信部、科技部、商务部、食药监局等六部委联合发布《医药工业发展规划指南》，提出要重点推进植入介入产品和医用材料，其中包括心脏瓣膜、可降解封堵器、组织器官诱导再生和修复材料等产品。支持产业发展的相关政策为动物源性植介入医疗器械行业发展营造了良好的外部环境。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-89222","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"QfRDpwQlT6pSuhq4nbLIPA==","EncryptionKey":"UWZSRHB3UWxUNnBTdWhxNG5iTElQQT09","Title":"佰仁医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-22T00:00:00","StockCode":"688198","StockTicker":"佰仁医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-22/1207551605.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=T7leBXT+AZ98+NJnuycWID2M2YJqTPHXOkIVNoChauJm48XhL16N7A==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688198/2020-04-22 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688198\t公司简称：佰仁医疗<br />北京佰仁医疗科技股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 重大风险提示<br />"},"Highlight":{"Content":["@6@64@&emsp;&emsp;2015年5月，国务院印发《中国制造2025》，将<em>生物医药及高性能医疗器械</em>作为战略产业发展方向。2016年11月，国务院印发《“十三五”国家战略性新兴产业发展规划》（国发[2016]67号），提出要加快组织器官修复和替代材料及植（介）入医疗器械产品创新和产业化。2016 年 12 月，国家发改委印发《“十三五”生物产业发展规划》（发改高技[2016]2665 号），提出要推动植（介）入产品创新发展，推动生物技术与材料技术的融合。2017年2月，国家发改委、工信部、科技部、商务部、食药监局等六部委联合发布《医药工业发展规划指南》，提出要重点推进植入介入产品和医用材料，其中包括心脏瓣膜、可降解封堵器、组织器官诱导再生和修复材料等产品。支持产业发展的相关政策为动物源性植介入医疗器械行业发展营造了良好的外部环境。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51174627","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"yOL+m75HEPUC7LMj9EEtrg==","EncryptionKey":"eU9MK203NUhFUFVDN0xNajlFRXRyZz09","Title":"泰瑞机器：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"603289","StockTicker":"泰瑞机器","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207528707.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=xEb/DQg4KoTbNK/QL3fXNf5wk5Y2Pzx3viCGcfuYpQyLtle+2btyfw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603289/2020-04-18 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603289 \u0000 \u0000\t公司简称：\u0000 泰瑞机器\u0000<br />&emsp;&emsp;泰瑞机器股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 4 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>生物医药及高性能医疗器械</em>等十大重点领域。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51175422","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"pPEdkps0KZ+Y8XMRi+Mu/A==","EncryptionKey":"cFBFZGtwczBLWitZOFhNUmkrTXUvQT09","Title":"新华医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"600587","StockTicker":"新华医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207528239.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=maHLYC074xlaCjLpQawDoiYlD2Q7PpfXPWpI/GVuesG3Vetdg401EA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600587/2020-04-18 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 600587 \u0000 \u0000 公司简称：\u0000 新华医疗\u0000<br />山东新华医疗器械股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;二 \u0000 O \u0000 二 \u0000 O \u0000 年\u0000四\u0000月十\u0000八\u0000日 \u0000<br />&emsp;&emsp;重要提示 \u0000<br />"},"Highlight":{"Content":["》明确把新材料、<em>生物医药及高性能医疗器械</em>作为重点发展"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51175423","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"rpF0bEgG/zv/SuejDmDVGw==","EncryptionKey":"cnBGMGJFZ0cvenYvU3VlakRtRFZHdz09","Title":"新华医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"600587","StockTicker":"新华医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207528228.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=DgCdAL/J/E7u3ExVSFoxLyOGekVw9WXBDrKK7xmQr5tk4SB7dSYbmQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600587/2020-04-18 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600587\t公司简称：新华医疗<br />山东新华医疗器械股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />&emsp;&emsp;二 O 二 O 年四月十八日<br />一 重要提示<br />"},"Highlight":{"Content":["@3@24@&emsp;&emsp;近年来，国家相继出台规划、指导措施等一系列扶持政策，促进医疗器械产业健康发展。《中国制造2025》明确把新材料、<em>生物医药及高性能医疗器械</em>作为重点发展的十大领域之一，提出提高医疗器械的创新能力和产业化水平，逐步摆脱高端医疗器械依赖进口的局面；《“十三五”国家科技创新规划》特别强调“十三五”时期将重点发展数字诊疗装备、体外诊断产品、健康促进关键技术、健康服务技术、养老助残技术等关键技术；《“健康中国2030”规划纲要》提出，未来15年，将深化医疗器械流通体制改革、强化医疗器械安全监管、加强高端医疗器械创新能力建设、推进医疗器械国产化。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51136932","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"6v11h7LDt/xglSHuExDfhQ==","EncryptionKey":"NnYxMWg3TER0L3hnbFNIdUV4RGZoUT09","Title":"昊华科技：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-16T00:00:00","StockCode":"600378","StockTicker":"昊华科技","Url":"http://static.cninfo.com.cn/finalpage/2020-04-16/1207507147.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"化学原料及化学制品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=VyJTq8nu5ypFDZeML7N/IIvnVcc6ELYZBXt/CjLLik+c7yZTxIi6AQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600378/2020-04-16 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600378 \u0000 \u0000\t公司简称：\u0000 昊华科技\u0000<br />昊华化工科技集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000<br />"},"Highlight":{"Content":["与新能源汽车、新材料、<em>生物医药及高性能医疗器械</em>等战略重点，引导社会各类资源集聚，推动"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51116174","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"SrodYRFnsJ3HZauVWLdFWg==","EncryptionKey":"U3JvZFlSRm5zSjNIWmF1VldMZEZXZz09","Title":"众业达：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-15T00:00:00","StockCode":"002441","StockTicker":"众业达","Url":"http://static.cninfo.com.cn/finalpage/2020-04-15/1207497621.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=1AGEUdNtvpkayZ8oM/3sVDwW7YvQJ/eHxyUWUSmzNMmMoEi9iZ2+Lg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002441/2020-04-15 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;众业达电气股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />众业达电气股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["新材料、<em>生物医药及高性能医疗器械</em>、农业机械装备。这些领域的发展将有利于带动工业电气分销、集成制造行业的发展。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51051316","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"eoQgCPoP2U7ceUnFA+o8ZQ==","EncryptionKey":"ZW9RZ0NQb1AyVTdjZVVuRkErbzhaUT09","Title":"戴维医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-10T00:00:00","StockCode":"300314","StockTicker":"戴维医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-10/1207471563.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Xvp1HNEk+ghLVTS3B7BYdisLla4EJ4C6T0nx0estOTJvOsaB8sMW+g==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300314/2020-04-10 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;宁波戴维医疗器械股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />宁波戴维医疗器械股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000015\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["把新材料、<em>生物医药及高性能医疗器械</em>作为重点发展的十大领域之一，提出要提高医疗器"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50921864","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"M4CHxILmf6R9vbA9nVDj3A==","EncryptionKey":"TTRDSHhJTG1mNlI5dmJBOW5WRGozQT09","Title":"康德莱：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"603987","StockTicker":"康德莱","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207432988.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=UfBS0vKxdx9lHlr8o6rTFr84s/O3jnOT9UWwziY7lK2mkE/8+qeqRA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603987/2020-03-31 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603987 \u0000 \u0000\t公司简称：\u0000 康德莱\u0000<br />上海康德莱企业发展集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000266\u0000<br />"},"Highlight":{"Content":["》明确把新材料、<em>生物医药及高性能医疗器械</em>作为重点发展的十大领"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-57304","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"dXI98vHYCyS3oiU5YqoNCA==","EncryptionKey":"ZFhJOTh2SFlDeVMzb2lVNVlxb05DQT09","Title":"海尔生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-26T00:00:00","StockCode":"688139","StockTicker":"海尔生物","Url":"http://static.cninfo.com.cn/finalpage/2020-03-26/1207405217.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=fu6ABWtHRuzfMp/2KCAX6gdL4fZWqvssthzphwo8/5LQzWrkPI2abA==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688139/2020-03-26 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688139\t公司简称：海尔生物<br />青岛海尔生物医疗股份有限公司<br />&emsp;&emsp;2019 年年度报告<br />尊敬的各位股东、各位合作伙伴、各位员工：<br />&emsp;&emsp;伴随着 2020 年非同寻常的开篇，我们一起进入了 21 世纪的第三个十年。<br />"},"Highlight":{"Content":["@18@150@&emsp;&emsp;同时，随着科学技术蓬勃发展，生物安全对民众健康、国家安全和人类发展的重要性日益提高，因此，也对生物安全细分领域的基础仪器设备提出了更高的要求，在国家政策引导和市场发展规律的双重作用下，通过自主创新实现国产化替代成为行业的大势所趋。2014年，国务院发布《关于印发深化医药卫生体制改革2014年重点工作任务的通知》，强调做好基本医疗器械产品国产化工作；2015年，国务院印发《中国制造2025》，并把“<em>生物医药及高性能医疗器械</em>”列为重点突破发展的十大领域之一；2018 年，国务院办公厅印发《深化医药卫生体制改革 2018 年下半年重点工作任务的通知》，再次强调“推进医疗器械国产化，促进创新产品应用推广”。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-57293","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"86SDxa8/EI5/kf3FWTZTZg==","EncryptionKey":"ODZTRHhhOC9FSTUva2YzRldUWlRaZz09","Title":"海尔生物：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-26T00:00:00","StockCode":"688139","StockTicker":"海尔生物","Url":"http://static.cninfo.com.cn/finalpage/2020-03-26/1207405228.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=7lInvPdixQBTsLXzKkNrWG20Fb/4PUfBsmcWOekpBtJ+kglUAHYxjg==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688139/2020-03-26 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688139\t公司简称：海尔生物<br />青岛海尔生物医疗股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 重大风险提示<br />"},"Highlight":{"Content":["@9@65@&emsp;&emsp;同时，随着科学技术蓬勃发展，生物安全对民众健康、国家安全和人类发展的重要性日益提高，因此，也对生物安全细分领域的基础仪器设备提出了更高的要求，在国家政策引导和市场发展规律的双重作用下，通过自主创新实现国产化替代成为行业的大势所趋。2014年，国务院发布《关于印发深化医药卫生体制改革2014年重点工作任务的通知》，强调做好基本医疗器械产品国产化工作；2015年，国务院印发《中国制造2025》，并把“<em>生物医药及高性能医疗器械</em>”列为重点突破发展的十大领域之一；2018 年，国务院办公厅印发《深化医药卫生体制改革 2018 年下半年重点工作任务的通知》，再次强调“推进医疗器械国产化，促进创新产品应用推广”。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50767362","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"dDn50Vqsr2e41TXDdx5NUw==","EncryptionKey":"ZERuNTBWcXNyMmU0MVRYRGR4NU5Vdz09","Title":"宝钛股份：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-20T00:00:00","StockCode":"600456","StockTicker":"宝钛股份","Url":"http://static.cninfo.com.cn/finalpage/2020-03-20/1207385691.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"有色金属冶炼和压延加工业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=fl/OIPjZH5ej0AaoPKyZovHjLq7lZOItMpxIo7T1jZdBpwNiUj4VBQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600456/2020-03-20 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600456\t公司简称：宝钛股份债券代码：155801/155802\t债券简称：19宝钛01/19宝钛02<br />&emsp;&emsp;宝鸡钛业股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指..."},"Highlight":{"Content":["@4@36@2、2019年，世界经济增速放缓，国内总体经济形势稳中有进、健康发展，但外部环境复杂多变，不稳定、不确定因素增多，经济下行压力加大。钛行业在国家持续深入推进供给侧结构改革和环保政策等多方面因素的影响下，部分低端落后产能、排放不达标钛加工企业相继出清退出市场，钛行业市场供求关系发生明显转变，供给格局持续优化，钛行业运行呈现出稳中向好的发展态势，但钛行业结构性产能过剩、高端产品生产供给能力不足，中低端产品竞争激烈、供大于求、同质化的矛盾依然突出，钛加工企业仍将面临复杂的市场竞争格局。随着国民经济结构战略性调整以及产业转型升级，为钛行业提供了重要的发展机遇，未来在航空、航天、船舶、核电、信息技术、高端装备制造、新能源、新材料、体育休闲、海水淡化、海洋工程装备、<em>生物医药及高性能医疗器械</em>等产业上，钛行业仍将有较大的市场需求和市场空间。根据公司产品转型升级的部署和安排，公司将着力提升公司钛材在航空、航天、舰船、兵器、信息技术、海洋、生物医药等领域的应用比例，进一步加大研发力度，建立项目专人跟踪、专人负责的机制，开展多项重点预研项目研究，为公司抢占高端市场、迅速占领行业制高点奠定基础，进一步巩固和提高公司的盈利能力和行业地位。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]}],"GroupKey":null,"GroupHits":[],"Aggregations":[{"AggKey":"companyCount","AggName":null,"Items":[{"N":"total","C":15,"M":0,"JsonTag":null}],"ItemList":[]},{"AggKey":"company","AggName":null,"Items":[{"N":"300143 盈康生命","C":2,"M":0,"JsonTag":null},{"N":"600587 新华医疗","C":2,"M":0,"JsonTag":null},{"N":"688139 海尔生物","C":2,"M":0,"JsonTag":null},{"N":"688198 佰仁医疗","C":2,"M":0,"JsonTag":null},{"N":"000831 五矿稀土","C":1,"M":0,"JsonTag":null},{"N":"002441 众业达","C":1,"M":0,"JsonTag":null},{"N":"002550 千红制药","C":1,"M":0,"JsonTag":null},{"N":"300314 戴维医疗","C":1,"M":0,"JsonTag":null},{"N":"300430 诚益通","C":1,"M":0,"JsonTag":null},{"N":"600378 昊华科技","C":1,"M":0,"JsonTag":null},{"N":"600456 宝钛股份","C":1,"M":0,"JsonTag":null},{"N":"603289 泰瑞机器","C":1,"M":0,"JsonTag":null},{"N":"603928 兴业股份","C":1,"M":0,"JsonTag":null},{"N":"603987 康德莱","C":1,"M":0,"JsonTag":null},{"N":"688333 铂力特","C":1,"M":0,"JsonTag":null}],"ItemList":[]}],"HighlightFilters":[{"Keyword":"生物医药及高性能医疗器械","IsApplied":false}],"TitleHighlights":[],"ContentHighlights":[],"IpoItems":[],"Message":null,"NickName":null,"PaymentStatus":"1","SubscriptionLimit":"20","CanPay":true,"ExpireTime":"2021-08-29","ResponseCode":100,"ResponseMessage":"","Token":"nmRnY1j%2bCGXKCM4bM4TTn3jQHDvW7eGIToGnu4ZfJe7o87Tw1S6SoYeBvRf7P4zvFXODclaHtVxIRE7b0lMXAcm3xzBVCmemI9xU6XNEZlu2%2bZhzV3HLkJCpf0KYW4T87k7%2fFlszrrk6TdJgZ2m0VQ%3d%3d","CommonSession":null}